The evolution of clinical outcomes in metastatic pancreatic adenocarcinoma: a 10-year experience at a tertiary referral center
CONCLUSIONS: In this study of real-world data, the median OS and PFS for all patients with mPDAC were equivalent before and after incorporating newer treatment regimens into the clinical practice.PMID:35400291 | DOI:10.1080/17474124.2022.2065259
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Authors: Moataz Ellithi Mohamed Abdallah McKenna Fischer Isaak Ailts John Fanta Kate Waligoske Matthew Bell Morgan E Nelson Jonathan Bleeker Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Eloxatin | Gastroenterology | Pancreas | Pancreatic Cancer | Study